Martina Weiner

Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom.

Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA.

Roche Ventures is the venture investment division of the pharmaceutical company F. Hoffmann-La Roche Ltd., which is a subsidiary of Roche Holding AG (SWX:ROG). The group is headquartered in Basel with operations and affiliates worldwide, and is a world leader in pharmaceuticals and diagnostics. The firm was founded in 2002.

First Berlin Equity Research GmbH (First Berlin) is an independent investment research firm headquartered in Berlin, Germany. The firm was founded by Martin Bailey in 1998. First Berlin provides independent equity research and market intelligence to banks, asset managers and other institutional investors on small and micro-cap companies in a variety of sectors. The equity research team analyses economic, market, industry and company data to optimize the performance of their clients’ investment portfolios and to help companies set their strategic direction. Their analysts offer stock recommendations and insights into industry trends and precise valuation perspectives through in-depth reports.

Rocket Internet is the venture capital division of Rocket Internet SE founded in 2007 by the Samwer brothers Marc, Alexander, and Oliver. The firm is headquartered in Berlin, Germany.

Advanced World Transport BV provides rail freight services. Its services include rail transport, rail sidings operation, intermodal transport, rail forwarding, freight wagon rental, and reclamation and groundworks. The company was founded in 2010 and is headquartered in Amsterdam, the Netherlands.

Pin-Pay SAL provides mobile payment and banking solutions. The firm’s platform allows its clients to use its mobile to access their bank accounts, recharge their phones, transfer money and pay bills, check their account balance, and perform internal funds transfers. The company was founded by Danny S. Abla in 2008 and is headquartered in Beirut, Lebanon.

Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom.

Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain.

Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom.

ReWind Therapeutics NV is a biotech company based in Leuven, Belgium that develops first-in-class remyelinating therapies for myelin-related diseases. The Belgian company's aim is to bring these therapies into fast-track clinical development. Myelin-related diseases, such as multiple sclerosis, are those where the myelin sheath surrounding nerves is damaged, leading to deficient nerve transmission that may affect multiple functions, including sensation, cognition, and movement, among others. ReWind Therapeutics develops first-in-class therapeutics designed to re-initiate the process of remyelination in patients suffering from major debilitating diseases such as multiple sclerosis, optic neuritis, or nerve injuries. The company's team has extensive R&D expertise and has built a strong patent estate for developing novel remyelination therapeutics. The company was founded in 2017 by Ku Leuven's Centre for Drug Design and Discovery (CD3) and Axxam S.p.A. The CEO of the company since 2021 is Anja Harmeier.

Pureos Partners AG (Pureos Partners) is a venture capital division of Bellevue Asset Management AG founded in 2017. The firm is headquartered in Zurich, Switzerland.

Orbit Biomedical, Inc. engages in a healthcare company. It aims to revolutionize gene and cell therapy treatment by setting a new standard for precise, targeted surgical delivery. The company was founded by Mike Keane in 2018 and is headquartered in Ambler, PA..

Zanui Holding GmbH provides online shopping services. The private company is based in Berlin, Germany. The CEOs of the German company are Gregor Bernd Janknecht, Arnd Lodowicks.

Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland.

Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom.

L.E.K. Consulting Group Ltd. operates as a management consulting firm. The company was founded on June 16,2017 and is headquartered in London, the United Kingdom.

Founded in 2018, Orbit Biomedical Ltd. is a British biotechnology company that engages in research and development. Part of Novartis AG, the company is based in Stevenage, UK.

Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022.

Corlieve Therapeutics SAS provides neurology services. The company was founded by Richard Porter, Valerie Crepel and Christophe Mulle in November 2019 and is headquartered in Paris, France.

Purespring Therapeutics Ltd. provides biotechnological research and experimental development services. The company was founded on April 1, 2020 and is headquartered in London, the United Kingdom.

Juwel 168. V V UG (haftungsbeschränkt) is a private company based in Berlin, Germany. The German company provides economic services. The CEO of the company is Arnt Jeschke.